Encomenda rápida

Humano SNCA/alpha-Synuclein clonagem de ADN ou de clonagem do gene (vector de clonagem), N-HA Etiqueta

    Folha de dadosAnálisesProdutos relacionadosProtocolos
    Humano SNCA Informações sobre o produto de clone de cDNA
    Gene_bank_ref_id:NM_000345.3
    Tamanho de cDNA:423bp
    Descrição de cDNA:Full length Clone DNA of Homo sapiens synuclein, alpha (non A4 component of amyloid precursor) with N terminal HA tag.
    Sinónimo de gene:PD1, NACP, PARK1, PARK4, MGC110988, SNCA
    Espécie:Human
    Vetor:pCMV3-N-HA
    Plasmid:
    Local de restrição:
    Sequência de etiqueta:HA Tag Sequence: TATCCTTACGACGTGCCTGACTACGCC
    Descrição da sequência:
    Sequencing primers:T7(TAATACGACTCACTATAGGG) BGH(TAGAAGGCACAGTCGAGG)
    ( We provide with SNCA qPCR primers for gene expression analysis, HP101621 )
    Promoter:Enhanced CMV mammalian cell promoter
    Application:Stable or Transient mammalian expression
    Antibiotic in E.coli:Kanamycin
    Antibiotic in mammalian cell:Hygromycin
    Shipping_carrier:Each tube contains lyophilized plasmid.
    Armazenamento:The lyophilized plasmid can be stored at room temperature for three months.
    HA Tag Info

    Human influenza hemagglutinin (HA) is a surface glycoprotein required for the infectivity of the human virus. The HA tag is derived from the HA-molecule corresponding to amino acids 98-106 has been extensively used as a general epitope tag in expression vectors. Many recombinant proteins have been engineered to express the HA tag, which does not appear to interfere with the bioactivity or the biodistribution of the recombinant protein. This tag facilitates the detection, isolation, and purification of the proteins.

    The actual HA tag is as follows: 5' TAC CCA TAC GAT GTT CCA GAT TAC GCT 3' or 5' TAT CCA TAT GAT GTT CCA GAT TAT GCT 3' The amino acid sequence is: YPYDVPDYA.

    Humano SNCA/alpha-Synuclein clonagem de ADN ou de clonagem do gene (vector de clonagem), N-HA Etiqueta on other vectors
    Humano SNCA/alpha-Synuclein clonagem de ADN ou de clonagem do gene (vector de clonagem), C-GFPSpark EtiquetaHG12093-ACG$225
    Humano SNCA/alpha-Synuclein clonagem de ADN ou de clonagem do gene (vector de clonagem), C-OFPSpark EtiquetaHG12093-ACR$225
    Humano SNCA/alpha-Synuclein clonagem de ADN ou de clonagem do gene (vector de clonagem), N-GFPSpark EtiquetaHG12093-ANG$225
    Humano SNCA/alpha-Synuclein clonagem de ADN ou de clonagem do gene (vector de clonagem), N-OFPSpark EtiquetaHG12093-ANR$225
    Humano SNCA/alpha-Synuclein clonagem de ADN ou de clonagem do gene (vector de clonagem), C-Flag EtiquetaHG12093-CF$195
    Humano SNCA/alpha-Synuclein clonagem de ADN ou de clonagem do gene (vector de clonagem), C-His EtiquetaHG12093-CH$195
    Humano SNCA/alpha-Synuclein clonagem de ADN ou de clonagem do gene (vector de clonagem), C-Myc EtiquetaHG12093-CM$195
    Humano SNCA/alpha-Synuclein clonagem de ADN ou de clonagem do gene (vector de clonagem), C-HA EtiquetaHG12093-CY$195
    Humano SNCA/alpha-Synuclein clonagem de ADN ou de clonagem do gene (vector de expressão)HG12093-G$75
    Humano SNCA/alpha-Synuclein clonagem de ADN ou de clonagem do gene (vector de clonagem), N-Flag EtiquetaHG12093-NF$195
    Humano SNCA/alpha-Synuclein clonagem de ADN ou de clonagem do gene (vector de clonagem), N-His EtiquetaHG12093-NH$195
    Humano SNCA/alpha-Synuclein clonagem de ADN ou de clonagem do gene (vector de clonagem), N-Myc EtiquetaHG12093-NM$195
    Humano SNCA/alpha-Synuclein clonagem de ADN ou de clonagem do gene (vector de clonagem), N-HA EtiquetaHG12093-NY$195
    Humano SNCA/alpha-Synuclein clonagem de ADN ou de clonagem do gene (vector de clonagem)HG12093-UT$195
     Saiba mais sobre vectores de expressão
    Product nameProduct name
    Fundo

    Alpha-Synuclein (alpha-Syn), also known as NACP or SNCA, exists as at least two structural isoforms: one is helix-rich, membrane-bound form that both the N- and C-terminal regions of alpha-synuclein are tightly associated with membranes and the other is disordered, cytosolic form. Synuclein is found predominantly in the presynaptic termini, in both free or membrane-bound forms. SNCA is extensively localized in nucleus of neurons. It has been shown that alpha-Synuclein was highly expressed in the mitochondria in olfactory bulb, hippocampus, striatum, and thalamus, where the cytosolic alpha-Synuclein was also rich. Normally the unstructured soluble type of alpha-synuclein can aggregate to form insoluble fibrils in pathological conditions characterized by Lewy bodies, such as Parkinson's disease, dementia with Lewy bodies and multiple system atrophy. SNCA abnormality and mitochondrial deficiency are two major changes in the brain of patients with Parkinson's disease (PD). In addition, alpha-synuclein is an abundant component of Lewy bodies in sporadic Parkinson's disease and diffuse Lewy body disease.

    Referências
  • Arima K, et al. (1998) Immunoelectron-microscopic demonstration of NACP / alpha-synuclein-epitopes onthe filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res. 808 (1): 93-100.
  • Arima K, et al. (1998) NACP / alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol. 96 (5): 439-44.
  • Lee HJ, et al. (2001) Membrane-bound alpha-Synuclein Has a High Aggregation Propensity and the Ability to Seed the Aggregation of the Cytosolic Form. The Journal of Biological Chemistry. 277: 671-8.
  • Size / Price
    Catálogo: HG12093-NY
    Preço de catálogo: 
    Preço:      (You Save: )
    Tamanho:
    Quantidade:+-
    Disponibilidade
    Acrescentar a carrinhoBulk Discount Requiry

    Datasheet & Documentation

    Contact Us
      Itens recentemente visualizados
        All information of our products is subject to change without notice. Please refer to COA enclosed in shipped package for the newest information.
        Tenha em atenção o seguinte: Todos os produtos destinam-se "A FINS EXCLUSIVOS DE INVESTIGAÇÃO E NÃO DEVEM SER UTILIZADOS PARA EFEITOS DE DIAGNÓSTICO OU TERAPÊUTICOS"